Aspen Aerogels, Inc. (ASPN) — Analyst outlook / Analyst consensus target is. Based on 23 analyst ratings, the consensus is bullish — 19 Buy, 3 Hold, 1 Sell.
The consensus price target is $30.71 (low: $18.00, high: $38.00), representing an upside of 827.8% from the current price $3.31.
Analysts estimate Earnings Per Share (EPS) of $0.12 and revenue of $0.45B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.17 vs est $0.12 (beat +41.7%). 2025: actual $-4.74 vs est $-4.11 (missed -15.2%). Analyst accuracy: 79%.
ASPN Stock — 12-Month Price Forecast
$30.71
▲ +827.79% Upside
Average Price Target
Based on 23 Wall Street analysts offering 12-month price targets for Aspen Aerogels, Inc., the average price target is $30.71, with a high forecast of $38.00, and a low forecast of $18.00.
The average price target represents a +827.79% change from the last price of $3.31.
Highest Price Target
$38.00
Average Price Target
$30.71
Lowest Price Target
$18.00
ASPN Analyst Ratings
Buy
Based on 23 analysts giving stock ratings to Aspen Aerogels, Inc. in the past 3 months
EPS Estimates — ASPN
79%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.17
vs Est $0.12
▲ 29.4% off
2025
Actual –$4.74
vs Est –$4.11
▼ 13.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — ASPN
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.453B
vs Est $0.450B
▲ 0.5% off
2025
Actual $0.271B
vs Est $0.274B
▼ 1.1% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
